Fulgent Genetics, Inc. (FLGT)
24.11
-0.67
(-2.70%)
USD |
NASDAQ |
Nov 20, 16:00
24.11
0.00 (0.00%)
After-Hours: 20:00
Fulgent Genetics Enterprise Value : 399.82M for Nov. 19, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 19, 2026 | 399.82M |
| November 18, 2026 | 409.53M |
| November 17, 2026 | 383.99M |
| November 16, 2026 | 380.24M |
| November 13, 2026 | 396.49M |
| November 12, 2026 | 401.76M |
| November 11, 2026 | 425.36M |
| November 10, 2026 | 427.58M |
| November 09, 2026 | 437.85M |
| November 06, 2026 | 370.94M |
| November 05, 2026 | 229.91M |
| November 04, 2026 | 258.23M |
| November 03, 2026 | 249.62M |
| November 02, 2026 | 247.40M |
| October 30, 2026 | 284.32M |
| October 29, 2026 | 313.75M |
| October 28, 2026 | 309.31M |
| October 27, 2026 | 286.54M |
| October 26, 2026 | 273.22M |
| October 23, 2026 | 269.89M |
| October 22, 2026 | 266.83M |
| October 21, 2026 | 270.72M |
| October 20, 2026 | 276.27M |
| October 19, 2026 | 269.89M |
| October 16, 2026 | 261.84M |
| Date | Value |
|---|---|
| October 15, 2026 | 304.31M |
| October 14, 2026 | 295.15M |
| October 13, 2026 | 296.54M |
| October 12, 2026 | 307.92M |
| October 09, 2026 | 315.42M |
| October 08, 2026 | 289.88M |
| October 07, 2026 | 282.93M |
| October 06, 2026 | 283.21M |
| October 05, 2026 | 335.13M |
| October 02, 2026 | 308.20M |
| October 01, 2026 | 303.20M |
| September 30, 2026 | 323.19M |
| September 29, 2026 | 354.47M |
| September 28, 2026 | 362.17M |
| September 25, 2026 | 357.77M |
| September 24, 2026 | 339.89M |
| September 23, 2026 | 332.18M |
| September 22, 2026 | 342.64M |
| September 21, 2026 | 339.61M |
| September 18, 2026 | 343.74M |
| September 17, 2026 | 348.14M |
| September 16, 2026 | 342.09M |
| September 15, 2026 | 332.46M |
| September 14, 2026 | 315.12M |
| September 11, 2026 | 309.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 34.39B |
| Labcorp Holdings, Inc. | 36.48B |
| OPKO Health, Inc. | 1.271B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.258B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.34M |
| Revenue (Quarterly) | 90.41M |
| Total Expenses (Quarterly) | 103.56M |
| EPS Diluted (Quarterly) | -0.4754 |
| Gross Profit Margin (Quarterly) | 32.58% |
| Profit Margin (Quarterly) | -14.75% |
| Earnings Yield | -12.81% |
| Normalized Earnings Yield | -12.28 |